Serum Vitamins A, D, and Zinc Levels in Children with Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome in Children

Abstract

Objective Vitamin D, due to its immunomodulating effect, zinc, and vitamin A, which affect cellular and humoral immunity, are thought to affect the clinical severity of coronavirus disease 2019 (COVID-19) infection. The present study evaluates the association between vitamin A, D, and zinc deficiencies and disease severity in pediatric patients with COVID-19 infections.

Methods The levels of vitamin A, D, and zinc at the time of diagnosis of 123 pediatric patients who presented to our hospital and were diagnosed as having hospitalized, nonhospitalized COVID-19 infection group, and multisystem inflammatory syndrome in children (MIS-C) were evaluated. The correlations of the measured levels with the disease severity and the need for intensive care or hospitalization were analyzed.

Results Among the 123 patients, 21.1% (n = 26), 42.2% (n = 52), and 36.7% (n = 45) had a diagnosis of MIS-C, belonged to the hospitalized COVID-19 infection group, or belonged to the nonhospitalized COVID-19 infection group, respectively. Zinc levels were significantly lower in the MIS-C group than in the nonhospitalized group (p < 0.05). Vitamin A levels were found to be significantly lower in the MIS-C group than in the nonhospitalized group (p < 0.01) and significantly lower in the hospitalized group when compared with the nonhospitalized group (p < 0.001). Deficiencies in vitamin A, vitamin D, and zinc levels were found to be most common in the MIS-C group (42.3%) and in hospitalized COVID-19 group (15.3%). In the nonhospitalized COVID-19 group, it was found to be the lowest at 6.6%.

Conclusion Based on the results of the present study and a literature review, it can be said that vitamin A, D, and zinc deficiencies may associate with the severity of COVID-19, although more studies are required to clarify this subject further.

Keywords

COVID-19 - pandemic - vitamin D - vitamin A - zinc

Ethical Approval

Approval from the ethics board of the university was obtained for the study (Decision Number: 2021/3270).

Publikationsverlauf

Eingereicht: 08. April 2022

Angenommen: 05. August 2022

Artikel online veröffentlicht:
16. September 2022

• References

• 1 Raisi-Estabragh Z, McCracken C, Bethell MS. et al. Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank. J Public Health (Oxf) 2020; 42 (03) 451-460
• 2 Radia T, Williams N, Agrawal P. et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev 2021; 38: 51-57
• 3 Raharusun P, Priambada S, Budiarti C, Agung E, Budi C. Patterns of COVID-19 mortality and vitamin D: an Indonesian study. SSRN Electron J 2020;
• 4 Headey D, Heidkamp R, Osendarp S. et al; Standing Together for Nutrition consortium. Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality. Lancet 2020; 396 (10250): 519-521
• 5 Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr 2001; 21: 167-192
• 6 Long KZ, Rosado JL, DuPont HL, Hertzmark E, Santos JI. Supplementation with vitamin A reduces watery diarrhoea and respiratory infections in Mexican children. Br J Nutr 2007; 97 (02) 337-343
• 7 Villamor E, Mbise R, Spiegelman D. et al. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth. Pediatrics 2002; 109 (01) E6
• 8 Aukrust P, Müller F, Ueland T, Svardal AM, Berge RK, Frøland SS. Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses. Eur J Clin Invest 2000; 30 (03) 252-259
• 9 Zemb P, Bergman P, Camargo Jr CA. et al. Vitamin D deficiency and the COVID-19 pandemic. J Glob Antimicrob Resist 2020; 22: 133-134
• 10 Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev 2021; 79 (03) 289-300
• 11 Ali N. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health 2020; 13 (10) 1373-1380
• 12 Science M, Johnstone J, Roth DE, Guyatt G, Loeb M. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. CMAJ 2012; 184 (10) E551-E561
• 13 Chang TS, Ding Y, Freund MK. et al. UCLA Health Data Mart Working Group. Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health System. medRxiv 2020; [Preprint]
• 14 Mendy A, Apewokin S, Wells AA, Morrow AL. Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 patients. medRxiv 2020; [Preprint]
• 15 Yuan X, Qian SY, Li Z, Zhang ZZ. Effect of zinc supplementation on infants with severe pneumonia. World J Pediatr 2016; 12 (02) 166-169
• 16 Holick MF, Binkley NC, Bischoff-Ferrari HA. et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96 (07) 1911-1930
• 17 Sommer A, Davidson FR. Annecy Accords. Assessment and control of vitamin A deficiency: the Annecy Accords. J Nutr 2002; 132 (9 Suppl): 2845S-2850S
• 18 Barnett JB, Hamer DH, Meydani SN. Low zinc status: a new risk factor for pneumonia in the elderly?. Nutr Rev 2010; 68 (01) 30-37
• 19 Alexander J, Tinkov A, Strand TA, Alehagen U, Skalny A, Aaseth J. Early nutritional interventions with zinc, selenium and vitamin d for raising anti-viral resistance against progressive COVID-19. Nutrients 2020; 12 (08) 2358
• 20 De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA. Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics [preprint]. Infect Dis (except. HIV AIDS (Auckl) 2020;
• 21 Guo YR, Cao QD, Hong ZS. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Mil Med Res 2020; 7 (01) 11
• 22 Gruber-Bzura BM. Vitamin D and influenza-prevention or therapy?. Int J Mol Sci 2018; 19 (08) 2419
• 23 Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system—working in harmony to reduce the risk of infection. Nutrients 2020; 12 (01) 236
• 24 Rondanelli M, Miccono A, Lamburghini S. et al. Self-care for common colds: the pivotal role of vitamin d, vitamin c, zinc, and Echinacea in three main immune interactive clusters (physical barriers, innate and adaptive immunity) involved during an episode of common colds-practical advice on dosages and on the time to take these nutrients/botanicals in order to prevent or treat common colds. Evid Based Complement Alternat Med 2018; 2018: 5813095
• 25 Tan CW, Ho LP, Kalimuddin S. et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B₁₂ in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition 2020; 79-80: 111017
• 26 Pimentel GD, Dela Vega MCM, Pichard C. Low vitamin D levels and increased neutrophil in patients admitted at ICU with COVID-19. Clin Nutr ESPEN 2021; 44: 466-468
• 27 Jevalikar G, Mithal A, Singh A. et al. Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19. Sci Rep 2021; 11 (01) 6258
• 28 Hernández JL, Nan D, Fernandez-Ayala M. et al. Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection. J Clin Endocrinol Metab 2021; 106: 1343-1353
• 29 Bayramoğlu E, Akkoç G, Ağbaş A. et al. The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital. Eur J Pediatr 2021; 180 (08) 2699-2705
• 30 Yılmaz K, Şen V. Is vitamin D deficiency a risk factor for COVID-19 in children?. Pediatr Pulmonol 2020; 55 (12) 3595-3601
• 31 Alipio M. Vitamin D supplementation could possibly improve clinical outcomes of patients infected with coronavirus-2019 (COVID-2019). SSRN Elect J 2020;
• 32 Al-Jarallah M, Rajan R, Dashti R. et al. In-hospital mortality in SARS-CoV-2 stratified by serum 25-hydroxy-vitamin D levels: a retrospective study. J Med Virol 2021; 93 (10) 5880-5885
• 33 Darma A, Athiyyah AF, Ranuh RG. et al. Zinc supplementation effect on the bronchial cilia length, the number of cilia, and the number of intact bronchial cell in zinc deficiency rats. Indones Biomed J 2020; 12: 1-84
• 34 Truong-Tran AQ, Carter J, Ruffin R, Zalewski PD. New insights into the role of zinc in the respiratory epithelium. Immunol Cell Biol 2001; 79 (02) 170-177
• 35 Sandstead HH, Prasad AS. Zinc intake and resistance to H1N1 influenza. Am J Public Health 2010; 100 (06) 970-971
• 36 Cakman I, Kirchner H, Rink L. Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J Interferon Cytokine Res 1997; 17 (08) 469-472
• 37 Lang CJ, Hansen M, Roscioli E. et al. Dietary zinc mediates inflammation and protects against wasting and metabolic derangement caused by sustained cigarette smoke exposure in mice. Biometals 2011; 24 (01) 23-39
• 38 Kahmann L, Uciechowski P, Warmuth S. et al. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res 2008; 11 (01) 227-237
• 39 Basnet S, Mathisen M, Strand TA. Oral zinc and common childhood infections—an update. J Trace Elem Med Biol 2015; 31: 163-166